- Home
- HL vs FMS Comparison
HL vs FMS Comparison
Compare HL & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HL | FMS |
|---|---|---|
| Founded | 1891 | 1996 |
| Country | United States | Germany |
| Employees | 1865 | N/A |
| Industry | Precious Metals | Misc Health and Biotechnology Services |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 14.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HL | FMS |
|---|---|---|
| Price | $19.22 | $22.86 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 7 | 2 |
| Target Price | $20.71 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 14.5M | 418.9K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | 0.08% | ★ 2.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.43 | $0.45 |
| Revenue Next Year | N/A | $3.76 |
| P/E Ratio | $44.94 | ★ $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.51 | $20.96 |
| 52 Week High | $34.17 | $30.46 |
Technical Indicators
Market Signals| Indicator | HL | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 49.44 |
| Support Level | $16.32 | $22.50 |
| Resistance Level | $21.12 | $24.08 |
| Average True Range (ATR) | 0.95 | 0.37 |
| MACD | 0.27 | 0.11 |
| Stochastic Oscillator | 56.24 | 48.41 |
Price Performance
Historical ComparisonAbout HL Hecla Mining Company
Hecla Mining Co produces and explores silver, gold, zinc, and other metals. The operating business segments are Greens Creek, Lucky Friday, Keno Hill, and Casa Berardi. It generates maximum revenue from the Greens Creek segment. Geographically, It operates in Canada, the United States, and Mexico, and it derives a majority of its revenue from the United States.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.